Results 41 to 50 of about 1,084 (158)

MOLECULAR PHYSIOLOGY OF THROMBOXANE A2 GENERATION IN PLATELETS [PDF]

open access: yes, 2010
Cardiovascular diseases are a major cause of mortality and morbidity in the developed countries. Anti-platelet therapy is a cornerstone treatment for patients with cardiovascular diseases.
Bhavaraju, Kamala
core   +1 more source

Systematic Analysis of the Transcriptome Profiles and Co-Expression Networks of Tumour Endothelial Cells Identifies Several Tumour-Associated Modules and Potential Therapeutic Targets in Hepatocellular Carcinoma [PDF]

open access: yes, 2021
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most common cause of cancer-related death, with tumour associated liver endothelial cells being thought to be major drivers in HCC progression.
Aizarani, N.   +4 more
core   +2 more sources

Acute coronary syndrome after liver transplantation in a young primary biliary cholangitis recipient with dyslipidemia: a case report [PDF]

open access: yes, 2022
BACKGROUND: Primary biliary cholangitis (PBC) is a chronic, progressive liver disease associated with dyslipidemia. There is a consensus that PBC does not accelerate coronary artery disease despite high cholesterol levels, so the screening test for the ...
Hatano, Etsuro   +9 more
core   +1 more source

Establishment of framework for classification/categorisation and labelling of medicinal drugs and driving [PDF]

open access: yes, 2011
The establishment of criteria for a European categorisation will have to serve most of the needs of all parties involved: health professionals, drug regulatory agencies, drug manufacturers and patients. Clear warnings and symbols are needed so patients
Fierro Lorenzo, María Inmaculada   +2 more
core   +1 more source

Abstracts

open access: yes, 2021
Research and Practice in Thrombosis and Haemostasis, Volume 5, Issue S2, October 2021.
wiley   +1 more source

Clinical Handbook of Antithrombotic : A Practical Guide [PDF]

open access: yes, 2021
Antithrombotic agents are high-risk medications associated with significant rates of medication errors. The use of antithrombotic agents is extensively high in cardiology and medical specialties; thus, a good understanding of antithrombotic agents is ...
Lawrence, Anchah   +2 more
core   +3 more sources

Pharmacogenetics of Carboxylesterase 1 [PDF]

open access: yes, 2017
Carboxylesterases (CESs) catalyze the hydrolysis of a variety of ester- and amide containing compounds to their respective free acids. The main CES isozymes involved in drug metabolism are carboxylesterases 1 and 2 (CES1 and CES2). CES1 contributes to an
Tarkiainen, Katriina
core  

Validation of developed method by RP-HPLC for estimation of Prasugrelin human plasma and studying the stability of the drugs in plasma [PDF]

open access: yes, 2018
This paper is concern with a reverse phase high performance liquid chromatography (RP-HPLC) bio-analytical method development and validation for Prasugrel in human plasma using photo diode array detector (PDA detector).
Ashutosh, Kumar S.   +3 more
core   +1 more source

Evaluation of the appropriateness of tirofiban use in accordance to current ACC/AHA guidelines [PDF]

open access: yes, 2016
Tirofiban is a tyrosine-derived non-peptide Glycoprotein IIb/IIIa (GP2b3a) inhibitor. GP2b3a inhibitor therapy during primary percutaneous coronary intervention (PCI) decreases the incidence of major adverse events as it directly affects the level of ...
Mithawala, Priyam
core   +1 more source

LATENTIATED PRODRUG APPROACH OF DRUGS: AN OVERVIEW [PDF]

open access: yes, 2021
Prodrugs, with their capability of declining the adverse events and elevating the bioavailability of certain drugs, have captured enormous attention throughout the world since the 20th century.
P. R., DHARUN   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy